Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading update

24 Nov 2014 07:00

RNS Number : 7387X
Elektron Technology PLC
24 November 2014
 



24 November 2014

 

Elektron Technology plc

 

Third quarter trading update

 

Elektron Technology plc (AIM: EKT, "Elektron" or the "Group"), the global technology group, provides an update on recent trading.

 

The Group is continuing to perform in line with the Board's expectations. Group sales for the third quarter from continuing operations amounted to £11.5m (2013: £11.8m) taking year to date sales to £33.6m (2013: £34.4m) with sales demand tracking the trend of the first half of the year. As expected the Group has seen some weakening in demand from its EMEA Connectivity distributor base due to difficult economic conditions and high stock levels. Conversely Instrumentation Monitoring and Control ("IMC") demand strengthened during the third quarter. The overdue sales backlog at 31 October had been lowered to £0.7 million (31 July 2014: £1.0 million; 31 January 2014: £2.1 million). There were no operating or financing related exceptional charges in the third quarter.

 

Net debt at 31 October was £2.7 million (31 July 2014: £4.7 million; 31 January 2014: £8.0 million).

 

The Group has begun to accelerate investment in key new product development programmes, in particular relating to its Checkit brand, with a number of strategic technical appointments complemented by outsourced development. Consequently the Group expects debt to rise in the final quarter but still be substantially below the half year position.

 

The Group continues to focus on maximising the performance of its existing portfolio of brands in the short term whilst developing and launching innovative new products to enable growth in the medium and longer term.

 

As announced at the half year results in September, the Board remains of the view that the Group's trading performance in the second half of the year will be similar to the first half.

 

John Wilson, Chief Executive Officer of Elektron said:

 

"The Group's delivery of a satisfactory performance in the third quarter is confirmation that our strategy remains on track. The Group is cash generative and we are placing considerable focus on using the funds raised earlier in the year to invest and execute our longer term strategy of building a high growth portfolio of brands through the introduction of best-in-class innovative products to the market." 

 

Enquiries:

 

Elektron Technology www.elektron-technology.com

+44 (0) 1223 371 000

John Wilson - Chief Executive Officer

Andy Weatherstone - Chief Financial Officer

finnCap (Nominated Adviser, Financial Adviser and Broker)

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

Malar Velaigam (Corporate Broking)

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Kay Larsen

 

 

Notes to Editors 

Elektron conceives designs and markets innovative engineered products and services for businesses at its technology hub in Cambridge. It has a multi skilled team of engineers and product line specialists focused on the opportunities created by disruptive global trends in the following areas: 

 

· Demand for ubiquitous power and data: Connectivity Solutions

· Growth in high precision manufacture: Nano-positioning

· Healthcare for the ageing population: Ophthalmology

· Connected customer experiences and service delivery: E-Commerce and E-Service

 

In addition it owns a portfolio of well-established products and brands which provide customer access and feedback. 

 

Elektron Technology is headquartered in Cambridge and its shares are admitted to trading on the AIM market of the London Stock Exchange. 

 

Forward looking statements 

Statements contained in this statement are based on the knowledge and information available to the Company's directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. To the extent that this Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward looking statements.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFELFMFFLSEDF
Date   Source Headline
8th Apr 20269:54 amRNSForm 8.5 (EPT/RI)
7th Apr 202611:44 amRNSForm 8.3 - Checkit plc
7th Apr 202610:30 amRNSForm 8.5 (EPT/RI)
1st Apr 202610:37 amRNSForm 8.5 (EPT/RI)
1st Apr 20269:38 amRNSForm 8.3 - Checkit PLC
1st Apr 20267:47 amRNSForm 8 (OPD) - Checkit plc
31st Mar 20262:50 pmEQSForm 8.3 - Checkit PLC
31st Mar 202611:29 amRNSForm 8.3 - Checkit plc
31st Mar 202611:12 amRNSHolding(s) in Company
31st Mar 202610:51 amRNSForm 8.5 (EPT/RI)
30th Mar 20261:58 pmRNSForm 8.3 - Checkit plc
30th Mar 202610:14 amRNSForm 8.5 (EPT/RI)
27th Mar 20263:39 pmRNSForm 8.3 Check it
27th Mar 20262:43 pmRNSForm 8.3 - Checkit PLC
27th Mar 202611:44 amRNSForm 8.3 - Checkit plc
27th Mar 202611:36 amEQSForm 8.3 - Checkit PLC
27th Mar 202610:40 amRNSForm 8.5 (EPT/RI)
27th Mar 202610:32 amRNSCheckit Plc - Form 8.3
26th Mar 202610:26 amRNSForm 8.3 - Checkit PLC
26th Mar 20267:45 amRNSDisclosure Table
26th Mar 20267:00 amRNSCommencement of Formal Sale Process
19th Feb 20267:00 amRNSFY26 Trading Update
21st Jan 202611:34 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSDirector/PDMR Shareholding
30th Oct 20251:00 pmRNSDirector/PDMR Shareholding
28th Oct 20257:00 amRNSDirector/PDMR Shareholding
13th Oct 20252:52 pmRNSGrant of options and PDMR dealing
25th Sep 20257:00 amRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSInterim Results
19th Jun 20252:36 pmRNSGrant of Options
5th Jun 20253:11 pmRNSResult of AGM
29th May 20257:00 amRNSPosting of Annual Report and Notice of AGM
22nd May 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSFinal Results
17th Apr 20257:00 amRNSNotice of Results and Investor Presentation
8th Apr 20257:00 amRNSStrategic update
20th Mar 202512:31 pmRNSForm 8.5 (EPT/RI) - Amendment
20th Mar 202510:21 amRNSForm 8.5 (EPT/RI)
19th Mar 202512:02 pmRNSResult of General Meeting
18th Mar 20259:43 amRNSForm 8.5 (EPT/RI)
18th Mar 20259:23 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 202512:01 pmRNSForm 8.5 (EPT/RI)
17th Mar 20258:56 amRNSForm 8.5 (EPT/NON-RI)
14th Mar 202511:57 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.